Nasal drug repurposing has seen a real resurgence recently, driven by several factors. From an economic perspective, partners benefit from reduced development costs, intellectual property (IP) creation, increased market share… Read More »
Diagnoses of chronic illnesses such as rheumatoid arthritis (RA), Crohn’s disease and osteoporosis are expected to skyrocket in the coming decade, resulting in growing use of patient-centric drug delivery devices… Read More »
Millions of patients worldwide living with rare, debilitating conditions are benefiting from developments in biopharmaceuticals and complex chemical entities as well as novel approaches to drug delivery. For example,… Read More »
Across the US, half of all adults live with a chronic disease – and many of them are prescribed a self-injectable therapy to help manage their condition. As the patient… Read More »
Over the years, many industry stakeholders and pharmaceutical manufacturers have come to realize the importance of patient training and the role it has on promoting healthy outcomes and effective disease… Read More »
The rapid advancement of biologic therapies has created numerous opportunities for improving patient self injection. As a result, every year, more patients are being introduced to both established and new… Read More »